Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility

Ítems similars

• Human Immunodeficiency Virus Type 1 Isolates with the Reverse Transcriptase (RT) Mutation Q145M Retain Nucleoside and Nonnucleoside RT Inhibitor Susceptibility
  per: Varghese, Vici, et al.
  Publicat: (2009)
• Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
  per: Melikian, George L., et al.
  Publicat: (2014)
• Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
  per: Shahriar, Rajin, et al.
  Publicat: (2009)
• HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
  per: Rhee, Soo-Yon, et al.
  Publicat: (2010)
• Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors
  per: Gonzales, Matthew J., et al.
  Publicat: (2003)